|
rs10865331
|
|
|
0.870 |
GeneticVariation |
BEFREE |
This is the first study that replicates in an independent cohort the association of the intergenic SNP rs10865331 with susceptibility to AS.
|
20810504 |
2010 |
|
rs10865331
|
|
A |
0.870 |
GeneticVariation |
GWASDB |
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.
|
20062062 |
2010 |
|
rs10865331
|
|
|
0.870 |
GeneticVariation |
BEFREE |
Association was also observed between AS and the intergenic region 2p15 (rs10865331, p = 0.023).
|
21068102 |
2011 |
|
rs10865331
|
|
A |
0.870 |
GeneticVariation |
GWASCAT |
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.
|
20062062 |
2010 |
|
rs10865331
|
|
|
0.870 |
GeneticVariation |
BEFREE |
Beyond that, we also demonstrated a strong relationship between rs10865331 and AS susceptibility (OR (95% CI) = 1.303(1.111-1.526)).
|
28493913 |
2017 |
|
rs10865331
|
|
A |
0.870 |
GeneticVariation |
GWASDB |
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.
|
21743469 |
2011 |
|
rs10865331
|
|
|
0.870 |
GeneticVariation |
BEFREE |
Through logistic regression, we built the AS-GRS model consisting of 5 genetic components: HLA-B27, 3 CNV (1q32.2, 13q13.1, and 16p13.3), and 1 SNP (rs10865331).
|
27909141 |
2016 |
|
rs10865331
|
|
|
0.870 |
GeneticVariation |
BEFREE |
We found that rs10865331 was significantly associated with AS susceptibility and with Bath AS Function Index (BASFI).
|
25184745 |
2014 |
|
rs10865331
|
|
|
0.870 |
GeneticVariation |
BEFREE |
We revealed 16 AS-associated variants with nominal evidence in Han Chinese, including rs10865331 (P=6.30×10-10), rs10050860 (P=4.09×10-5) and rs8070463 (P=1.03×10-4).
|
31523044 |
2019 |
|
rs10865331
|
|
|
0.870 |
GeneticVariation |
BEFREE |
This is the first confirmation in a nonwhite population that genetic polymorphisms of rs27037, rs27434, and rs10865331 are associated with AS, implicating common pathogenetic mechanisms in Korean and white patients with AS.
|
21041274 |
2011 |
|
rs10865331
|
|
A |
0.870 |
GeneticVariation |
GWASCAT |
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.
|
21743469 |
2011 |
|
rs8070463
|
|
|
0.820 |
GeneticVariation |
BEFREE |
We revealed 16 AS-associated variants with nominal evidence in Han Chinese, including rs10865331 (P=6.30×10-10), rs10050860 (P=4.09×10-5) and rs8070463 (P=1.03×10-4).
|
31523044 |
2019 |
|
rs8070463
|
|
C |
0.820 |
GeneticVariation |
GWASCAT |
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.
|
21743469 |
2011 |
|
rs8070463
|
|
C |
0.820 |
GeneticVariation |
GWASDB |
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.
|
21743469 |
2011 |
|
rs8070463
|
|
|
0.820 |
GeneticVariation |
BEFREE |
The rs7379457 SNP in PPARGC1B, the rs1395621 and rs9438876 SNPs in RUNX3, and the rs8070463 SNP in TBKBP1 are related to the severity of AS in Chinese Han population.
|
23637848 |
2013 |
|
rs10440635
|
|
A |
0.810 |
GeneticVariation |
GWASCAT |
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.
|
21743469 |
2011 |
|
rs10440635
|
|
|
0.810 |
GeneticVariation |
BEFREE |
The rs11062357 SNP in JARID1A, the rs2607142 SNP in JMY and rs10440635 in PTGER4 are related to severity of AS.
|
24069348 |
2013 |
|
rs10440635
|
|
A |
0.810 |
GeneticVariation |
GWASDB |
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.
|
21743469 |
2011 |
|
rs2242944
|
|
|
0.810 |
GeneticVariation |
BEFREE |
A recent genome-wide association study has identified 2 single-nucleotide polymorphisms (SNP) associated with ankylosing spondylitis (AS), rs10865331 (2p15) and rs2242944 (21q22).
|
20810504 |
2010 |
|
rs2242944
|
|
A |
0.810 |
GeneticVariation |
GWASDB |
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.
|
20062062 |
2010 |
|
rs2242944
|
|
|
0.810 |
GeneticVariation |
GWASCAT |
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.
|
20062062 |
2010 |
|
rs2310173
|
|
A |
0.810 |
GeneticVariation |
GWASDB |
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.
|
20062062 |
2010 |
|
rs2310173
|
|
|
0.810 |
GeneticVariation |
BEFREE |
However, we observed that CARD9 allele C (p = 0.012) and genotype CC (p = 0.012) were significant protective factors against AS only in HLA-B27-negative patients, and IL1R2 rs2310173 genotype GT was mildly protective against AS only in HLA-B27-negative status.
|
26590821 |
2016 |
|
rs2310173
|
|
A |
0.810 |
GeneticVariation |
GWASCAT |
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.
|
20062062 |
2010 |
|
rs4552569
|
|
|
0.810 |
GeneticVariation |
BEFREE |
The correlation between genetic polymorphisms, AS activity indexes, (namely, BASDAI, BASFI and BAS-G) and AS complications (uveitis and inflammatory bowel disease) were tested using the markers, rs4552569 and rs17095830.
|
23308121 |
2013 |